Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	513.37	1,238	483.9	735.32	1,128
Short-Term Investments	652.18	862.1	1,025	1,608	1,058
Trading Asset Securities	41.66	41.93	37.87	6.48	-
Cash & Short-Term Investments	1,207	2,142	1,547	2,350	2,186
Cash Growth	-43.64%	38.44%	-34.16%	7.49%	21.44%
Accounts Receivable	37.84	41.77	32.35	10.12	164.81
Other Receivables	7.71	8.37	26.65	5.12	5.5
Receivables	45.55	50.15	59.01	15.25	170.31
Inventory	34.1	10.77	10.06	-	45.48
Prepaid Expenses	30.34	24.89	21.42	24.68	17.75
Total Current Assets	1,317	2,228	1,638	2,390	2,420
Property, Plant & Equipment	355.47	321.82	340.24	44.52	666.03
Long-Term Investments	-	-	1,876	1,847	-
Goodwill	106.74	106.74	106.74	39.23	72.19
Other Intangible Assets	55.01	64.33	73.44	39.71	141.33
Long-Term Deferred Tax Assets	32.95	-	-	-	4.12
Other Long-Term Assets	10.37	26.46	5.59	4.58	10.93
Total Assets	1,878	2,747	4,040	4,364	3,314
Accounts Payable	12	5.36	3.94	0.05	28.26
Accrued Expenses	113.03	98.01	73.09	68.33	73.19
Current Portion of Leases	54.56	47.15	36.69	14.53	23.53
Current Income Taxes Payable	-	37.97	56.78	66.74	41.75
Current Unearned Revenue	4.51	3.11	0.86	0.65	11.13
Other Current Liabilities	31.54	30.16	27.17	10	19.73
Total Current Liabilities	215.64	221.76	198.51	160.3	197.59
Long-Term Debt	-	-	-	-	12.94
Long-Term Leases	113.84	139.59	162.22	15.71	456.3
Long-Term Deferred Tax Liabilities	12.36	14.31	15.74	-	-
Total Liabilities	341.84	375.65	376.48	176	666.83
Common Stock	922.45	922.45	878.4	732.34	665.03
Additional Paid-In Capital	1,339	1,341	1,344	1,349	1,933
Retained Earnings	-792.94	31.25	1,355	2,072	-525.91
Treasury Stock	-5.25	-10.6	-10.6	-10.6	-20.48
Comprehensive Income & Other	56.73	36.18	30.94	-12.49	-6.68
Total Common Equity	1,520	2,320	3,597	4,130	2,045
Minority Interest	15.71	51.51	66.1	58.15	602.47
Shareholders' Equity	1,536	2,371	3,664	4,188	2,648
Total Liabilities & Equity	1,878	2,747	4,040	4,364	3,314
Total Debt	168.4	186.74	198.91	30.24	492.76
Net Cash (Debt)	1,039	1,955	1,348	2,320	1,693
Net Cash Growth	-46.87%	45.01%	-41.87%	36.98%	0.68%
Net Cash Per Share	11.27	21.24	14.65	25.19	18.48
Filing Date Shares Outstanding	92.14	92.04	92.02	92.02	91.63
Total Common Shares Outstanding	92.14	92.04	92.02	92.02	91.63
Working Capital	1,102	2,006	1,439	2,230	2,222
Book Value Per Share	16.50	25.21	39.10	44.89	22.32
Tangible Book Value	1,358	2,149	3,417	4,051	1,832
Tangible Book Value Per Share	14.74	23.35	37.14	44.03	19.99
Machinery	229.55	178.49	168.97	46.34	239.52
Leasehold Improvements	84.96	46.22	45.6	6.43	74.41

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.